IMRAN MIR A
SEC Form 4 insider trading activity
IMRAN MIR A has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jul 23, 2026.
On the most recent filing, IMRAN MIR A is listed as Director, 10% Owner at Rani Therapeutics Holdings, Inc. Inside the rolling window, IMRAN MIR A reported 2 open-market purchases totaling $1.3M in RANI and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,083,334 RANI shares on Oct 23, 2025, worth $1.3M.
Companies traded
Other insiders at RANI
Insider Buying
$1.3M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has IMRAN MIR A made?
IMRAN MIR A has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does IMRAN MIR A trade?
IMRAN MIR A has filed SEC Form 4 disclosures for 1 company, including RANI.
When was IMRAN MIR A's most recent SEC Form 4 filing?
IMRAN MIR A's most recent SEC Form 4 filing on Tracefour is dated Jul 23, 2026.
What is IMRAN MIR A's total buy and sell value in the current window?
Inside the rolling retention window, IMRAN MIR A bought $1.3M and sold $0 based on SEC Form 4 filings.
What was IMRAN MIR A's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,083,334 RANI shares on 2025-10-23, worth $1.3M, per SEC Form 4 filings.